Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
Iviensan F Manalo,1 Kathleen E Gilbert,2 Jashin J Wu3 1Medical College of Georgia, Georgia Regents University, Augusta, GA, 2Indiana University School of Medicine, Indianapolis, IN, 3Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA Background: Although o...
Guardado en:
Autores principales: | Manalo IF, Gilbert KE, Wu JJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ecb229a25f3f498e8ef852181e26ceca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski C
Publicado: (2015) -
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016) -
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
por: Abrouk M, et al.
Publicado: (2016) -
Long-term safety of biologics in the treatment of psoriasis
por: Panchal MR, et al.
Publicado: (2013) -
Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
por: Levy LL, et al.
Publicado: (2012)